Dennis Cho - 02 Nov 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer
Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for Dennis Cho
Issuer symbol
TWST
Transactions as of
02 Nov 2023
Net transactions value
+$247,583
Form type
4
Filing time
06 Nov 2023, 16:13:46 UTC
Previous filing
03 Oct 2023
Next filing
07 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $280,783 +13,859 +34% $20.26 54,303 02 Nov 2023 Direct F1
transaction TWST Common Stock Tax liability $33,201 -1,918 -3.5% $17.31 52,385 02 Nov 2023 Direct F2
transaction TWST Common Stock Award $0 +29,518 +56% $0.000000 81,903 02 Nov 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement.
F2 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F3 Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer